Skip to main content

NC's Life Science Growth Blossoms to $86B, Supports 260,000 Jobs

The newly published 2016 Evidence and Opportunity: Impact of Life Sciences in North Carolina says the state now has over 650 life science companies that directly employ 63,000 people and account for 260,000 jobs overall, providing $2.2 billion in state and local tax revenues and $86 billion in total economic impact.

Vote Again: RTP’s UVision360 Made Round 2 of Medtech Startup Showdown

Last week we announced that RTP’s own UVision360 Hysteroscopy Systems was competing in the MD+DI annual Medtech Startup Showdown. With the support of our scientific community, UVision has made it to Round 2.

Shengmin Sang of NCA&T Wins Innovation for Impact Grand Prize

Shengmin Sang, Ph.D., associate professor and lead scientist in the Center for Excellence in Post-Harvest Technologies at North Carolina Agricultural and Technical State University, was awarded the inaugural Innovation for Impact $11,000 Grand Prize Thursday night, March 30, for his research to prevent colon cancer by pairing the classic wonder drug aspirin with an active ingredient in ginger.

Vote today for RTP’s UVision360 Hysteroscopy Systems

RTP's UVision 360 has been chosen by Medical Device and Diagnostic Industry (MD+DI), a print and online magazine, to participate in its annual Medtech Startup Showdown. North Carolina's life science and technology community can ensure one of our own makes it to Round 2 by voting now.

Humacyte Vessel Gets Special FDA Review Designation

Humacyte, a Research Triangle Park-based biotechnology company focused on regenerative medicine, has won one of the first Regenerative Medicine Advanced Therapy (RMAT) designations from the U.S. Food and Drug Administration

Finalists Named in Inaugural SoBran/NCBiotech Life Science Research Prize Competition

Five research scientists from three North Carolina universities are finalists in the inaugural Innovation for Impact Prize competition, co-sponsored by SoBran Bioscience and the Piedmont Triad Office of the North Carolina Biotechnology Center.

Positive Early Phase 2 Lung Cancer Data Buoy Heat Bio

Heat Biologics (Nasdaq:HTBX) has reported early positive results in a Phase 2 trial of its immunotherapy lung cancer treatment.

NCBiotech Grant Recipient Doubles Back With $100K Teaching Prize

A UNC Asheville chemistry professor who received a $100,000 grant from the North Carolina Biotechnology Center has matched the funding and received a major honor in the process.

Durham's Qualyst Launches New Test for Avoiding Liver Toxicity

Durham-based Qualyst Transporter Systems (QTS) has launched a new test that can steer drug developers away from compounds that could cause liver damage.

Heat Biologics Gets Good News from Early Cancer Trial

Heat Biologics, a Durham company developing immunotherapies to fight cancer, has reported positive results from a Phase 1b trial of its combination treatment for non-small cell lung cancer.

Pages

Subscribe to RSS - NCBiotech